Modeling the molecular epigenetic profile of psychosis in prenatally stressed mice

Progress in Molecular Biology and Translational Science

Volumn 128, Issue C, 2014, Pages 89-101

  Guidotti, Alessandro ^a   Dong, Erbo ^a   Tueting, Patricia ^a   Grayson, Dennis R ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; 5 HYDROXYMETHYLCYTOSINE; 5 METHYLCYTOSINE; ATYPICAL ANTIPSYCHOTIC AGENT; BIOLOGICAL MARKER; CLOZAPINE; DIOXYGENASE; DNA DEMETHYLASE; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; GLUTAMATE RECEPTOR; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; OXYGENASE; TET METHYLCYTOSINE DIOXYGENASE 1; UNCLASSIFIED DRUG;

ADULT; ANIMAL BEHAVIOR; ANIMAL MODEL; ARTICLE; AUTOPSY; BIPOLAR DISORDER; BRAIN; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DNA METHYLATION; EARLY INTERVENTION; EARLY LIFE STRESS; EPIGENETICS; FACE VALIDITY; GENE EXPRESSION; HUMAN; MARE; MENTAL PATIENT; MOLECULAR GENETICS; MOLECULAR MODEL; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRENATAL STRESS; PRIORITY JOURNAL; PROGENY; PROMOTER REGION; PSYCHOSIS; SCHIZOPHRENIA; TREATMENT RESPONSE; ANIMAL; DISEASE COURSE; DISEASE MODEL; FEMALE; GENETIC EPIGENESIS; GENETICS; MENTAL STRESS; PREGNANCY; PRENATAL EXPOSURE;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPIGENESIS, GENETIC; FEMALE; HUMANS; MICE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOTIC DISORDERS; STRESS, PSYCHOLOGICAL;

EID: 84927776416     PISSN: 18771173     EISSN: 18780814     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800977-2.00004-8     Document Type: Chapter

References (63)

1. Ptak C, Petronis A. Epigenetics and complex disease: from etiology to new therapeutics. Annu Rev Pharmacol Toxicol. 2008;48:257-276.
2. Grayson DR, Guidotti A. The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. Neuropsychopharmacology. 2013;38:138-166.
3. Akbarian S, Kim JJ, Potkin SG, et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 1995;52:258-266.
4. Guidotti A, Auta J, Davis JM, et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry. 2000;57:1061-1069.
5. Benes FM, Lim B, Matzilevich D, Walsh JP, Subburaju S, Minns M. Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc Natl Acad Sci USA. 2007;104:10164-10169.
6. Fatemi SH, Earle JA, McMenomy T. Reduction in reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry. 2000;5:654-665.
7. Impagnatiello F, Guidotti A, Pesold C, et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA. 1998;95:15718-15723.
8. Lewis DA, Hashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci. 2005;6:312-324.
9. Wong J, Hyde TM, Cassano HL, Deep-Soboslay A, Kleinman JE, Weickert CS. Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia. Neuroscience. 2010;169:1071-1084.
10. Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry. 2003;8:592-610.
11. Ikegame T, Bundo M, Sunaga F, et al. DNA methylation analysis of BDNF gene promoters in peripheral blood cells of schizophrenia patients. Neurosci Res. 2013;77:208-214.
12. Mill J, Tang T, Kaminsky Z, et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet. 2008;82:696-711.
13. Veldic M, Caruncho JH, Liu WS, et al. DNA methyltransferase-1 (DNMT1) is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proc Natl Acad Sci USA. 2004;101:348-353.
14. Veldic M, Guidotti A, Maloku E, Davis JM, Costa E. In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. Proc Natl Acad Sci USA. 2005;102:2152-2157.
15. Veldic M, Kadriu B, Maloku E, et al. Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder. Schizophr Res. 2007;91:51-61.
16. Ruzicka WB, Zhubi A, Veldic M, Grayson DR, Costa E, Guidotti A. Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection. Mol Psychiatry. 2007;12:385-397.
17. Zhubi A, Veldic M, Puri NV, et al. An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes. Schizophr Res. 2009;111:115-122.
18. Kadriu B, Guidotti A, Chen Y, Grayson DR. The DNA methyltransferases1 (DNMT1) and 3a (DNMT3a) co-localize with GAD67-positive neurons in the GAD67-GFP mouse brain. J Comp Neurol. 2012;9:1951-1964.
19. Guidotti A, Ruzicka W, Grayson DR, et al. S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis. Neuroreport. 2007;18:57-60.
20. Grayson DR, Jia X, Chen Y, et al. Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci USA. 2005;102:9341-9346.
21. Abdolmaleky HM, Cheng KH, Russo A, et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am J Med Genet B Neuropsychiatr Genet. 2005;134B:60-66.
22. Tochigi M, Iwamoto K, Bundo M, et al. Methylation status of the reelin promoter region in the brain of schizophrenic patients. Biol Psychiatry. 2008;63:530-533.
23. Gavin DEP, Sharma RP, Chase KA, Matrisciano F, Dong E, Guidotti A. Growth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosis. Neuropsychopharmacology. 2012;2:531-542.
24. Mitchell CP, Chen Y, Kundakovic M, Costa E, Grayson DR. Histone deacetylase inhibitors decrease reelin promoter methylation in vitro. J Neurochem. 2005;93:483-492.
25. Noh JS, Sharma RP, Veldic M, et al. DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures. Proc Natl Acad Sci USA. 2005;102:1749-1754.
26. Chen Y, Kundakovic M, Agis-Balboa RC, Pinna G, Grayson DR. Induction of the reelin promoter by retinoic acid is mediated by Sp1. J Neurochem. 2007;183:650-665.
27. Kundakovic M, Chen Y, Guidotti A, Grayson DR. The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes. Mol Pharmacol. 2009;75:342-354.
28. Dong E, Gavin DP, Chen Y, Davis J. Upregulation of TET1 and down-regulation of APOBEC3A and APOBEC3C in the parietal cortex of psychotic patients. Transl Psychiatry. 2012;2:e159.
29. Houston I, Peter CJ, Mitchell A, Straubhaar J, Rogaev E, Akbarian S. Epigenetics in the human brain. Neuropsychopharmacology. 2013;38:183-197.
30. Guidotti A, Auta J, Chen Y, et al. Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology. 2011;60:1007-1016.
31. Wyatt RJ, Termini BA, Davis J. Biochemical and sleep studies of schizophrenia. A review of the literature 1960-1970. Schizophr Bull. 1971;4:10-44.
32. Tremolizzo L, Doueiri M-S, Dong E, et al. Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol Psychiatry. 2005;57:500-509.
33. Dong E, Guidotti A, Grayson DR, Costa E. Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. Proc Natl Acad Sci USA. 2007;104:4676-4681.
34. Costa E, Chen Y, Davis J, et al. Reelin and schizophrenia: a disease at the interface of the genome and the epigenome. Mol Interv. 2002;2:47-57.
35. Guo JU, Su Y, Zhong C, Ming GL, Song H. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell. 2011;145:423-434.
36. Massart R, Suderman M, Provencal N, et al. Hydroxymethylation and DNA methylation profiles in the prefrontal cortex of the non-human primate rhesus macaque and the impact of maternal deprivation on hydroxymethylation. Neuroscience. 2014;268: 139-148.
37. Koenig JI, Elmer GI, Shepard PD, et al. Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia. Behav Brain Res. 2005;156:251-261.
38. Matrisciano F, Tueting P, Dalal I, et al. Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice. Neuropharmacology. 2013;68:184-194.
39. Matrisciano F, Tueting P, Maccari S, Nicoletti F, Guidotti A. Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice. Neuropsychopharmacology. 2012;37:929-938.
40. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gammaaminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry. 2000;57:237-245.
41. Lipska BK, Lerman DN, Khaing ZZ, Weickert CS, Weinberger DR. Gene expression in dopamine and GABA systems in an animal model of schizophrenia: effects of antipsychotic drugs. Eur J Neurosci. 2003;18:391-402.
42. Fatemi SH, Folsom TD, Reutiman TJ, Novak J, Engel RH. Comparative gene expression study of the chronic exposure to clozapine and haloperidol in rat frontal cortex. Schizophr Res. 2011;134:211-218.
43. Marco E, Mao CC, Cheney DL, Revuelta A, Costa E. The effects of antipsychotics on the turnover rate of GABA and acetylcholine in rat brain nuclei. Nature. 1976;264:363-365.
44. Brown AS. The environment and susceptibility to schizophrenia. Prog Neurobiol. 2011;93:23-58.
45. Brown AS, Patterson PH. Maternal infection and schizophrenia: implications for prevention. Schizophr Bull. 2011;37:284-290.
46. Mednick SA, Huttunen MO, Machón RA. Prenatal influenza infections and adult schizophrenia. Schizophr Bull. 1994;20:263-267.
47. Izumoto Y, Inoue S, Yasuda N. Schizophrenia and the influenza epidemics of 1957 in Japan. Biol Psychiatry. 1999;46:119-124.
48. Susser E, Neugebauer R, Hoek HW, et al. Schizophrenia after prenatal famine. Further evidence. Arch Gen Psychiatry. 1996;53:25-31.
49. Szyf M. Epigenetics, DNA methylation, and chromatin modifying drugs. Annu Rev Pharmacol Toxicol. 2009;49:243-263.
50. Zhang TY, Labonté B, Wen XL, Turecki G, Meaney MJ. Epigenetic mechanisms for the early environmental regulation of hippocampal glucocorticoid receptor gene expression in rodents and humans. Neuropsychopharmacology. 2013;38:111-123.
51. McGowan PO, Sasaki A, D'Alessio AC, et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci. 2009;12:342-348.
52. Schmidt MJ, Mirnics K. Neurodevelopment, GABA system dysfunction, and schizophrenia. Neuropsychopharmacology. 2014, http://dx.doi.org/10.1038/npp.2014.95.
53. Fine R, Zhang J, Stevens HE. Prenatal stress and inhibitory neuron systems: implications for neuropsychiatric disorders. Mol Psychiatry. 2014;19:641-651.
54. Stevens HE, Su T, Yanagawa Y, Vaccarino FM. Prenatal stress delays inhibitory neuron progenitor migration in the developing neocortex. Psychoneuroendocrinology. 2013;38:509-521.
55. Uchida T, Furukawa T, Iwata S, Yanagawa Y, Fukuda A. Selective loss of parvalbuminpositive GABAergic interneurons in the cerebral cortex of maternally stressed Gad1-heterozygous mouse offspring. Transl Psychiatry. 2014;4:e371.
56. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci. 2006;9:519-525.
57. Roth TL, Zoladz PR, Sweatt JD, Diamond DM. Epigenetic modification of hippocampal Bdnf DNA in adult rats in an animal model of post-traumatic stress disorder. J Psychiatr Res. 2011;45:919-926.
58. Guidotti A, Auta J, Davis JM, et al. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology (Berl). 2005;180:191-205.
59. Lewis DA, González-Burgos G. Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology. 2008;33:141-165.
60. Meek LR, Dittel PL, Sheehan MC, Chan JY, Kjolhaug SR. Effects of stress during pregnancy on maternal behavior in mice. Physiol Behav. 2001;72:473-479.
61. Lisman JE, Coyle JT, Green RW, et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 2008;31:234-242.
62. Dong E, Chen Y, Gavin DP, Grayson DR, Guidotti A. Valproate induces DNA demethylation in nuclear extracts from adult mouse brain. Epigenetics. 2010;5:730-735.
63. Guidotti A, Dong E, Kundakovic M, Satta R, Grayson DR, Costa E. Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling. Trends Pharmacol Sci. 2009;30:55-60.